Persistent Fetal Vasculature: Management and Results - PowerPoint PPT Presentation

1 / 8
About This Presentation
Title:

Persistent Fetal Vasculature: Management and Results

Description:

Persistent Fetal Vasculature: Management and Results. M rcia Beatriz Tartarella ... Haddad R, Font RL, Reeser F. Persistent Hyperplastic primary vitreous: a ... – PowerPoint PPT presentation

Number of Views:634
Avg rating:3.0/5.0
Slides: 9
Provided by: Rodr158
Category:

less

Transcript and Presenter's Notes

Title: Persistent Fetal Vasculature: Management and Results


1
Persistent Fetal Vasculature Management and
Results
  • Márcia Beatriz Tartarella
  • Rodrigo Ueno Takahagi
  • Ana Paula Silvério Rodrigues


Federal University of São Paulo
UNIFESP Brasil Head of Congenital Cataract
Service Fellow of Congenital Cataract Service
tartarella_at_hotmail.com
2
PURPOSE
Persistent Fetal Vasculature (PFV-PHPV) is a
common congenital developmental anomaly of the
eye that results following failure of the
embryological primary vitreous and hyaloid
vasculature to regress 1-3. It typically presents
unilaterally4 without associated systemic
findings1. PFV can be differentiated into
anterior, posterior and mixed forms, according to
the affected intraocular structures 5-9 .
To describe ocular features, management and
results in patients with persistent fetal
vasculature.
No financial interest
3
MATERIALS AND METHODS
A retrospective study in 27 children with
PFV-PHPV was performed. The following data were
analyzed
Sex Age at Diagnosis Systemic Features Birth
History Laterality Clinical Presentation
Axial Length Ecography Ocular Doppler Age at
Surgery Surgery Technique
Visual Acuity Before Surgery Visual Acuity After
Surgery Follow up Period Complication after
Surgery Additional Procedures
4

RESULTS
  • 14 male x 13 female 29 eyes

Graphic 2.Distribution of patients according to
laterality disease
Graphic 1. Distribution of patients according to
their ages at diagnosis

Graphic 3. Distribution of eyes affected
according to the clinical presentation

  Sistemic feature Patients None
13 Prematurity 4 L
ow weight at birth 8 13 Trissomy 1 CMV mother
infection 1
Table 1. Distribution of patients according to
their sistemic features
5
RESULTS
  • Microftalmia 14 eyes (58)
  • Age at surgery 25 days of life to 3years and
    10 months (mean 14,65 months).
  • Surgery 19 eyes (56)

Graphic 4. Distribution of eyes according to the
surgery technique performed
  • Follow up period 2 months to 4 years and
    11months ( mean 21 months).

6
RESULTS
  • Post-op complications 12 eyes (61)

Table 2. Distribution of eyes according to the
complications after surgery
Complication after surgery Eyes None

7 37 Posterior
Sinechiae 5 26.3 Retinal Detachment 5
26.3 Opacification of Posterior
Capsule 3 15.8 Phithisis Bulbi 3
15.8 Pearls over IOL 3
15.8 Leucoma 2 10.5 Pupil membrane 2
10.5
  • Additional procedures in 3 eyes 1 Yag laser
    capsulotomy, 1 sinechiae removal and 1 aspiration
    of pearls over IOL.

Graphic 6. Distribution of eyes according to
their visual acuity before and after surgery.
7
CONCLUSION PFV-PHPV
Mixed form 80 Lensectomy anterior
vitrectomy 50 Phacoaspiration IOL
21 Phacoaspiration 29 Post operative
complication 61 Surgery is one available
therapy which must be adjusted to patients ocular
features and visual recovering expectation.
Severe complications (26) may be present in the
management of PFV and patients family must be
aware of that.
tartarella_at_hotmail.com
8
REFERENCES
  • Gurwood AS, Silbert M. Persistent hyperplastic
    primary vitreous Clinical Review. Clin Eye Vis
    Care 2000(12) 131-137.
  • Goldberg MF. Persistent fetal vasculature (PFV)
    an integrated interpretation of signs and
    symptoms associated with persistent hyperplastic
    primary vitreous (PHPV) LIV Edward Jackson
    Memorial Lecture. Am J Ophthalmol
    1997124587-626.
  • Duke-Elder S. System of ophthalmology. St. Louis
    The C.V. Mosby Company, 1963624.
  • Haddad R, Font RL, Reeser F. Persistent
    Hyperplastic primary vitreous a
    clinicalpathologic study of 62 cases and review
    of literature. Surv Ophthalmol. 197823123-134.
  • Pollard Z. Results of treatment of persistent
    hyperplastic primary vitreous. Ophthalmic Surg.
    199122(1)48.
  • Pollard Z. Treatment of persistent hyperplastic
    primary vitreous. J. Ophthalmic Nurs Technol
    199110(4)155-159.
  • Dass AB, Trese MT. Persistent hyperplastic
    primary vitreous. In Yanoff M, Duker JS,
    editors. Opthtalmology. Philadelphia Mosby,
    1999 1-48.
  • Marshmann WE, Jan JE, Lyons CI. Neurologica
    abnormalities associated with persistent
    hyperplastic primary vitreous. Can J Ophthalmol
    1999 34(1)21.
  • Filho JBF, Filho HL.Possibilidades cirúrgicas na
    persistência do vítreo primário hiperplásico.
    Rev.Bras Oftalmol 199554(12) 931-34.
Write a Comment
User Comments (0)
About PowerShow.com